Doceree names cybersecurity expert as new CTO

Marketing technology company Doceree appointed Anil Dobhal as global chief technology officer, the Parsippany company announced April 27.

Dobhal brings more than 24 years of tech and cybersecurity experience to the company, which allows brands and media agencies to reach health care professionals on networks within their digital workflow. Doceree said Dobhal will lead its global technology and product teams in the U.S., Europe and those in emerging markets.

In past positions, Dobhal has built scalable data security systems and says he “intends to replicate those vast learnings from consumer space to build extensive designs and structures that will enrich our programmatic offerings to serve the varied market needs.” He has worked for companies including Times Internet Ltd. , Expedia, One97 Communications and GlobalLogic.

Doceree’s marketing technology identifies and targets health care professionals using AI, data integration and data analytics, giving brands and media agencies a streamlined method to reach them. Earlier this month, the company announced the completion of a $11 million Series A funding round led by Eight Roads Ventures to expand upon its offerings.

“Pharma marketing is going through transformational times with hybrid approaches taking centerstage for most business. We are excited about Anil being a part of our next crucial journey of growth and expansion,” Dr. Harshit Jain, Doceree founder and global CEO — and a 2022 NJBIZ Digi-Tech Innovator Awards honoree — said in a statement. “We are focused on empowering our clients and partners with high-end technology solutions led by artificial intelligence (AI) and machine learning (ML). Anil’s deep expertise in programmatic design will help us utilize humungous data to churn valuable insights for our partners world over, enabling them to make key business decisions and optimize business outcomes in a very secure and transparent manner.”

Dobhal added, “I am excited to join Doceree at this critical juncture when it is building a sustainable and scalable global programmatic ecosystem for the pharma and life sciences industry.”

Comments are closed.